Next New Releases from NCBI BookshelfDupilumab (Dupixent): Therapeutic area: Chronic rhinosinusitis with nasal polyps: Reimbursement Review [Internet].Dupilumab (Dupixent): Therapeutic area: Chronic rhinosinusitis with nasal polyps: Reimbursement Review [Internet].